Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1000 of 1958 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/06
End: 01/31/08
Due: 01/31/09
Phase: N/A
Priority: Normal
Start: 08/13/21
End: 04/02/22
Due: 04/02/23
Phase: N/A
Priority: Normal
Start: 11/02/20
End: 05/17/21
Due: 05/17/22
Phase: N/A
Priority: Normal
Start: 10/01/15
End: 01/15/18
Due: 01/15/19
A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus
Phase: N/A
Priority: Normal
Start: 07/31/12
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 11/19/18
End: 01/03/19
Due: 01/03/20
Phase: N/A
Priority: Normal
Start: 01/31/23
End: 04/04/23
Due: 04/04/24
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 02/28/18
Due: 02/28/19
Phase: N/A
Priority: Normal
Start: 11/30/03
End: 12/31/04
Due: 12/31/05
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 11/30/16
Due: 11/30/17
Phase: N/A
Priority: Normal
Start: 11/16/20
End: 11/09/22
Due: 11/09/23
Phase: N/A
Priority: Normal
Start: 04/30/99
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: 08/31/03
End: 11/30/04
Due: 11/30/05
Phase: N/A
Priority: Normal
Start: 02/28/13
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 09/30/11
Due: 09/30/12
Phase: N/A
Priority: Normal
Start: 06/30/16
End: 05/31/17
Due: 05/31/18
Phase: N/A
Priority: Normal
Start: 09/03/18
End: 02/07/22
Due: 02/07/23
Phase: N/A
Priority: Normal
Start: 04/30/09
End: 12/31/09
Due: 12/31/10
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 04/30/11
Due: 04/30/12
Phase: N/A
Priority: Normal
Start: 12/31/11
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 04/13/21
End: 04/30/28
Due: 04/30/29
Phase: N/A
Priority: Normal
Start: 02/03/25
End: 04/15/25
Due: 04/15/26
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 09/30/26
Due: 09/30/27
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 02/28/27
Due: 02/28/28